Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ukraine court to consider bankruptcy case against Ferrexpo subsidiary

(Sharecast News) - Ferrexpo confirmed on Thursday that an application to initiate bankruptcy proceedings against its Ukrainian subsidiary, Ferrexpo Poltava Mining (FPM), has been accepted for consideration by the Commercial Court of the Poltava region. The company said the application was filed by LLC 'Financial Company' Maxi Capital on 9 May, in relation to a contested UAH 4.7bn ($112.5m) sureties claim.

A preparatory court hearing was scheduled for 27 May, though no formal proceedings had commenced.

Ferrexpo emphasised that the claim remained under appeal at Ukraine's Supreme Court, which had suspended enforcement of the ruling pending a final decision.

At its most recent hearing on 12 May, the Supreme Court assigned the matter to a nine-judge panel, with a date for further proceedings yet to be set.

The company maintained that the claim was without merit in its view, but said it had fully provisioned for the amount in its 2023 and 2024 financial year accounts, citing legal uncertainty.

The contested claim concerns sureties allegedly issued by FPM for the now-insolvent Bank Finance & Credit, which has been in liquidation since 2015.

Ferrexpo said it was continuing to vigorously defend its position, and expected the bankruptcy court to consider the unresolved legal status of the claim in its upcoming hearing.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.